403 Tumor-infiltrating lymphocytes (TIL) with inducible and membrane-bound IL-12 exhibit superior antitumor activity in vitro

• Patrick Innamarato,
• Yongliang Zhang,
• Nathan Gilbert,
• Judy Fang,
• Hequn Yin

Affiliations

Patrick Innamarato

Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA

Yongliang Zhang

1School of Automotive Engineering, Qingdao University of Technology, Qingdao, China

Nathan Gilbert

Iovance Biotherapeutics, Inc, San Carlos, CA, USA

Judy Fang

Iovance Biotherapeutics, Inc, San Carlos, CA, USA

Hequn Yin

Iovance Biotherapeutics, Inc, San Carlos, CA, USA